沙特阿拉伯关于治疗牛皮关节炎的共识建议 (2023年)
Ibrahim Abdulrazag Al-Homood1,2, Nayef Al Ghanim3, Mohammad Ibrahim Ahmad Fatani4
1Medical Specialties Department, Rheumatology Section, King Fahad Medical City, Riyadh, Saudi Arabia. alhomoodibrahim@yahoo.com.
Clinical rheumatology
|January 13, 2024
概括
这项研究制定了在沙特阿拉伯治疗牛皮关节炎 (PsA) 的生物治疗的共识建议. 它解决了针对最佳的PsA治疗和监测的国家指南的缺乏问题.
科学领域:
- 风湿病学和皮肤病学
- 炎症性疾病 炎症性疾病
- 肌肉骨健康 肌肉骨健康
背景情况:
- 牛皮关节炎 (PsA) 呈现复杂的肌肉骨和非肌肉骨症状,需要多学科的方法.
- 沙特阿拉伯缺乏统一的国家共识导致PSA管理的变化,特别是与生物制剂.
- 早期诊断和管理对于改善患者的生活质量至关重要.
研究的目的:
- 在沙特阿拉伯建立基于证据的共识建议,用于在PsA管理中使用和监测生物疗法.
- 为了解决该国PsA治疗方案的现有不确定性和变异性.
- 为最佳的PsA护理提供指导,考虑各种患者需求和国际标准.
主要方法:
- 沙特卫生部成立了一个由皮肤科医生,风湿病学家和药剂师组成的多学科工作组.
- 在2021年12月至2022年3月期间,使用名义组技术进行了五次共识研讨会.
- 该小组讨论了适应性,监测,治疗目标,查,预防措施以及在PsA中进行生物治疗的特殊考虑.
主要成果:
- 为了在PsA管理中最佳使用和监测生物治疗,制定了共识建议.
- 这些建议考虑了不同PSA领域的各种疾病活动工具 (例如DAPSA,ASDAS,MDA).
- 为特殊人群提供指导,包括患有并发病的人群,孕妇/哺乳期妇女以及儿科/青少年患者.
结论:
- 开发的共识文件为沙特阿拉伯的PSA管理提供了实际建议,将国际准则与当地需求相结合.
- 这些建议旨在规范生物制剂的使用,确保适当的处方和监测.
- 该文件将定期更新,以反映PsA治疗中的新数据和新出现的治疗选择.
相关概念视频
01:20The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K
01:26Peptic Ulcer Disease IV: Management
94
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
94
01:29Chronic Pancreatitis II: Collaborative Care
92
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
92
01:29Inflammatory Bowel Disease IV: Pharmacological Management
127
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
127
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
183
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
183
01:19Mesenchymal Stem Cells
4.7K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.7K